Govt To Provide Private Doctors With Oral Covid Drugs
"); jQuery("#212 h3").html("

"); });
2022-04-03 HKT 05:33
The Government late on Saturday announced that it would gradually provide free Covid-19 oral drugs, namely Paxlovid and Molnupiravir, to private doctors with a view to enabling them to prescribe these two drugs to suitable Covid-19 patients.
"Our top priority now is not only to suppress the epidemic and reduce infection, but also to strengthen the protection for the elderly and children, and to reduce the numbers of severe cases and deaths caused by the epidemic. As the guardians of Hong Kong's public health and the well-being of our citizens, all healthcare professionals in Hong Kong have an obligatory duty to stand at the forefront of the fight against the epidemic and to mobilise all available manpower to support various anti-epidemic measures.
In addition to enlisting support from private hospitals and private doctors in the fight against the epidemic in different roles earlier, we also call upon private doctors to help treat the patients, especially high-risk ones, to reduce the risk of deterioration of their clinical conditions," a spokesman for the Food and Health Bureau said.
At present, the Hospital Authority (HA) prescribes the two Covid-19 oral drugs Paxlovid and Molnupiravir to patients at various facilities, including HA hospitals, community treatment facilities, designated clinics and residential care homes for the elderly. The nursing team from the Patient Support Call Centre of the HA also proactively contacts patients from high-risk groups for prescription of the oral drugs at designated clinics.
The government statement added that private doctors should accord priority to support and treat high-risk patients as far as practicable, including those aged 60 or above, children aged 5 or below, women at 28 or more weeks of pregnancy, and immunocompromised patients such as organ transplant recipients and those with immune system disorders or long-term use of immunosuppressive drugs. It also said that private doctors should not charge patients any fee for the Covid-19 oral drugs.
Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity
Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more
BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom
BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more
Webinar: When Account Takeover Moves Past Onboarding
Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more
JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson
JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more
Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term
The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more
Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal
Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more
